StockNews.com lowered shares of CorVel (NASDAQ:CRVL – Free Report) from a buy rating to a hold rating in a research note published on Friday.
CorVel Stock Performance
CorVel stock opened at $247.21 on Friday. The stock has a market cap of $4.23 billion, a PE ratio of 57.22 and a beta of 1.08. CorVel has a one year low of $187.92 and a one year high of $265.14. The stock has a fifty day moving average of $243.15 and a 200 day moving average of $232.35.
Insiders Place Their Bets
In other CorVel news, CFO Brandon O’brien sold 813 shares of the company’s stock in a transaction dated Wednesday, February 21st. The stock was sold at an average price of $260.00, for a total value of $211,380.00. Following the completion of the sale, the chief financial officer now owns 7,299 shares in the company, valued at $1,897,740. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other news, CFO Brandon O’brien sold 813 shares of the company’s stock in a transaction dated Wednesday, February 21st. The stock was sold at an average price of $260.00, for a total value of $211,380.00. Following the completion of the transaction, the chief financial officer now owns 7,299 shares of the company’s stock, valued at $1,897,740. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Chairman V Gordon Clemons sold 1,000 shares of the company’s stock in a transaction dated Wednesday, February 21st. The stock was sold at an average price of $264.00, for a total value of $264,000.00. Following the completion of the transaction, the chairman now directly owns 310,534 shares of the company’s stock, valued at approximately $81,980,976. The disclosure for this sale can be found here. Insiders sold a total of 11,543 shares of company stock worth $2,881,792 over the last quarter. 48.71% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On CorVel
CorVel Company Profile
CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.
Further Reading
- Five stocks we like better than CorVel
- There Are Different Types of Stock To Invest In
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 3 Value Stocks You Can Buy Before They Become Big
- What to Know About Investing in Penny Stocks
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.